BiomeSense

company

About

BiomeSense is a developing novel technologies to enable continuous, at-home monitoring of the human microbiome.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$2.42M
Industries
Bioinformatics,Biotechnology,Life Science,Medical
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2.68M
BiomeSense has raised a total of $2.68M in funding over 2 rounds. Their latest funding was raised on Jan 6, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 6, 2021 Grant $255.65K 1 National Science Foundation Detail
Oct 2, 2019 Seed $2.42M 2 BioX Clan Detail

Investors

Number of Lead Investors
Number of Investors
2
3
BiomeSense is funded by 3 investors. National Science Foundation and BioX Clan are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
BioX Clan Yes Seed
Seerave Foundation Seed